A trial of bortezomib and thalidomide in people with myeloma whose kidneys are not working well (OPTIMAL)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Myeloma

Status:

Closed

Phase:

Phase 2

Details

This trial is comparing 2 drugs called bortezomib and thalidomide for newly diagnosed myeloma. It is for people who have myeloma and whose kidneys are not working well.

Recruitment start: 21 November 2014

Recruitment end: 31 March 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr. Karthik Ramasamy

Supported by

Bloodwise

Janssen-Cilag

NIHR Clinical Research Network: Cancer

Oxford University Hospitals NHS Trust

Warwick Clinical Trials Unit

Last reviewed: 31 March 2019

CRUK internal database number: 12218

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Help and support

Questions for your doctor

What to ask your doctor about clinical trials.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.